Extendicare (TSE:EXE – Free Report) had its price target upped by Canaccord Genuity Group from C$37.00 to C$44.00 in a research note published on Monday morning,BayStreet.CA reports. The brokerage currently has a buy rating on the stock.
Several other research firms have also weighed in on EXE. BMO Capital Markets lifted their price objective on Extendicare from C$30.00 to C$38.00 in a research report on Wednesday, May 13th. Desjardins cut their target price on Extendicare from C$40.00 to C$39.00 and set a “buy” rating on the stock in a research report on Monday. TD raised their target price on Extendicare from C$32.00 to C$39.00 and gave the stock a “buy” rating in a research note on Monday, May 11th. Finally, National Bank Financial raised their target price on Extendicare from C$34.00 to C$40.00 and gave the stock an “outperform” rating in a research note on Wednesday, May 27th. One investment analyst has rated the stock with a Strong Buy rating and seven have given a Buy rating to the company’s stock. Based on data from MarketBeat, Extendicare presently has an average rating of “Buy” and a consensus target price of C$35.44.
Read Our Latest Stock Analysis on EXE
Extendicare Trading Up 1.2%
Extendicare (TSE:EXE – Get Free Report) last released its earnings results on Thursday, August 6th. The company reported C$0.32 earnings per share (EPS) for the quarter. The business had revenue of C$611.04 million for the quarter. Extendicare had a net margin of 6.99% and a return on equity of 45.35%. On average, sell-side analysts predict that Extendicare will post 0.6134729 EPS for the current year.
Extendicare Announces Dividend
The business also recently announced a monthly dividend, which will be paid on Monday, August 17th. Investors of record on Monday, August 17th will be paid a dividend of $0.0441 per share. The ex-dividend date of this dividend is Friday, July 31st. This represents a c) annualized dividend and a yield of 1.6%. Extendicare’s dividend payout ratio is currently 39.23%.
About Extendicare
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Featured Stories
- Five stocks we like better than Extendicare
- GE Vernova’s AI Power Boom Faces a Profit Test
- Cardinal Health Earnings: Can Perfection Get Priced In Twice?
- Nebius’ Q2 Beat Shows the AI Bottleneck Is Capacity, Not Demand
- Legacy Jet Builders Stall While Embraer Accelerates to New Highs
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
